Cue Biopharma (CUE)
(Delayed Data from NSDQ)
$0.98 USD
-0.10 (-9.26%)
Updated Jul 3, 2024 01:00 PM ET
After-Market: $0.98 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth A Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/13/24 |
---|---|
Current Quarter | -0.29 |
EPS Last Quarter | -0.25 |
Last EPS Surprise | 16.67% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.97 |
Next Year | -0.92 |
EPS (TTM) | -1.06 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.12M | 1.07M | 11.59M | 13.75M |
# of Estimates | 3 | 4 | 3 | 4 |
High Estimate | 2.15M | 2.08M | 17.30M | 45.00M |
Low Estimate | 0.20M | 0.20M | 4.72M | 2.00M |
Year ago Sales | 1.38M | 2.10M | 5.49M | 11.59M |
Year over Year Growth Est. | -19.06% | -49.10% | 111.11% | 18.64% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.29 | -0.25 | -0.97 | -0.92 |
# of Estimates | 4 | 4 | 4 | 4 |
Most Recent Consensus | NA | NA | NA | NA |
High Estimate | -0.24 | -0.19 | -0.66 | -0.47 |
Low Estimate | -0.34 | -0.32 | -1.20 | -1.59 |
Year ago EPS | -0.29 | -0.24 | -1.11 | -0.97 |
Year over Year Growth Est. | 0.00% | -4.17% | 12.61% | 4.64% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 1 | 3 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 0 | 0 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.29 | -0.25 | -0.97 | -0.92 |
7 Days Ago | -0.29 | -0.25 | -0.97 | -0.92 |
30 Days Ago | -0.29 | -0.25 | -0.97 | -0.92 |
60 Days Ago | -0.29 | -0.27 | -1.01 | -0.94 |
90 Days Ago | -0.31 | -0.29 | -1.12 | -1.14 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.29 | -0.25 | -0.97 | -0.92 |
Zacks Consensus Estimate | -0.29 | -0.25 | -0.97 | -0.92 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.25 | -0.28 | -0.24 | -0.29 | NA |
Estimate | -0.30 | NA | -0.30 | -0.30 | NA |
Difference | 0.05 | NA | 0.06 | 0.01 | 0.04 |
Surprise | 16.67% | NA | 20.00% | 3.33% | 13.33% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more